Bayer Schering Pharma AG

Overview

Bayer Schering Pharma AG was a pharmaceutical company known for its innovation in healthcare, focusing on areas such as oncology, women's healthcare, and cardiology. It was a subsidiary of Bayer AG, a global enterprise with core competencies in the Life Science fields of health care and nutrition.

Therapeutic areas

API / Drug Master Files

Bayer Schering Pharma AG holds 0 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• FLUDARA FILM-COATED TABLETSInactive2007-03-07
• ASOPRISNILInactive2004-07-15
• FLUDARABINE PHOSPHATEInactive2000-06-15
• ILOPROST B-CYCLODEXRIN CLATHRATEInactive1995-10-12
• MEGESTROL ACETATEInactive1984-03-15
• HYDROCORTISONEInactive1982-11-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Bayer Schering Pharma AG in our records. PharmaTek screens the full directory against live FDA enforcement data.